Persistent Kirsten Rat Sarcoma (KRAS)-epidermal growth factor receptor (EGFR) pathway activation cooperates with TGFβ signaling to endow PDAC and TNBC tumor cells with chemoresistance, metastatic dissemination, and early recurrence [1,10,11,12]. This evidence concerns the gene EGFR and neoplasm.